{"database": "lobbying", "table": "lobbying_activities", "rows": [[1552824, "efb665c6-67a8-4b91-bb4b-24ebada1ad86", "Q2", "CHRISTY ELLERBEE CONSULTING, LLC", 401103332, "INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.)", 2014, "second_quarter", "PHA", "Educating on Medically assisted treatment (MAT) within the opioid addiction disease space.", "HOUSE OF REPRESENTATIVES", null, null, 0, 0, "2014-07-16T13:17:47.043000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1552824"], "units": {}, "query_ms": 0.4031269927509129, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}